Holmes Biopharma, Inc. (LMB) Reports Q3 Loss of $0.12/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
Go back to Holmes Biopharma, Inc. (LMB) Reports Q3 Loss of $0.12/Share
November 14, 2017 4:09 PM EST
Third Quarter 2017 Revenues of $121.3 million; Service Revenues of
$25.5 million
Conference Call Scheduled for 9:00am ET Wednesday November 15, 2017
PITTSBURGH--(BUSINESS WIRE)--
Limbach Holdings, Inc. (NASDAQ: LMB) (Limbach or the Company) today
announced financial results for the quarter ended September 30, 2017.
Revenues increased 2.1% versus the prior year period to $121.3 million
in the third quarter of 2017. Service segment revenue of $25.5 million
grew 23.0% from the prior year quarter while Construction segment
revenues declined 2.3% due to backlog booked in the strong second
quarter that was not scheduled to commence work until after Q3.
Other key... More
